Log In
Print
BCIQ
Print
Print this Print this
 

R118

Also known as: AMPK activator

  Manage Alerts
Collapse Summary General Information
Company Rigel Pharmaceuticals Inc.
DescriptionActivator of AMP-activated protein kinase (AMPK)
Molecular Target AMP-activated protein kinase (AMPK)
Mechanism of ActionAMP-activated protein kinase (AMPK) activator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), or peripheral vascular disease in patients who exhibit exercise intolerance
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today